A tighter archive for life-science signals.
Search once, then narrow by source or topic.
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and Mo...
Cytiva, Veeda Lifesciences drive biopharma innovation with new host cell protein services centre - IndiaMedToday
Cytiva, Veeda Lifesciences drive biopharma innovation with new host cell protein services centre - IndiaMedToday
Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center - Express Pharma
Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center - Express Pharma
Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center - Pharmabiz.com
Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center - Pharmabiz.com
Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development - BioSpectrum Asia
Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development BioSpectrum Asia
Cellular Origines partners with Johnson & Johnson - European Biotechnology Magazine
Cellular Origines partners with Johnson & Johnson European Biotechnology Magazine
UCL Cytiva Centre of Excellence (COE) - University College London
UCL Cytiva Centre of Excellence (COE) University College London
Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy in China - Endpoints News
Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy in China Endpoints News
Producer Cell Lines: Large-Scale Gene Therapy Hitmakers - GEN - Genetic Engineering and Biotechnology News
Producer Cell Lines: Large-Scale Gene Therapy Hitmakers GEN - Genetic Engineering and Biotechnology News
Xcellerex 500 L and 2,000 L Bioreactors - GEN - Genetic Engineering and Biotechnology News
Xcellerex 500 L and 2,000 L Bioreactors GEN - Genetic Engineering and Biotechnology News
Cytiva and Asimov Collaborate on NextGen Cell Line Design and Process Development - GEN - Genetic Engineering and Biotechnology News
Cytiva and Asimov Collaborate on NextGen Cell Line Design and Process Development GEN - Genetic Engineering and Biotechnology News
Cytiva broadens Xcellerex X-platform to include 500 L and 2000 L bioreactors - SelectScience
Cytiva broadens Xcellerex X-platform to include 500 L and 2000 L bioreactors SelectScience
Cellular Origins and Cytiva Are Collaborating To Deliver Automated Robotic Manufacturing Capabilities for Cell and Gene Therapies - Technology Networks
Cellular Origins and Cytiva Are Collaborating To Deliver Automated Robotic Manufacturing Capabilities for Cell and Gene Therapies Technology Networks
Cytiva and Cellular Origins Team Up on Delivering Automated CGT Manufacturing - BioPharm International
Cytiva and Cellular Origins Team Up on Delivering Automated CGT Manufacturing BioPharm International
Cellular Origins, Cytiva Partner on Robotic Mfg. Capabilities for CGTs - Contract Pharma
Cellular Origins, Cytiva Partner on Robotic Mfg. Capabilities for CGTs Contract Pharma
CAR-NK: bringing cellular immunotherapy to the masses - Nature
CAR-NK: bringing cellular immunotherapy to the masses Nature
Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform - GEN - Genetic Engineering and Biotechnology News
Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform GEN - Genetic Engineering and Biotechnology News
Cytiva Introduces ELEVECTA Cell Lines - Contract Pharma
Cytiva Introduces ELEVECTA Cell Lines Contract Pharma
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page